Abiopharma

Satellos to Present Clinical Program Updates at ICNMD 2026

INmune Bio Inc. Achieves MHRA Approval of PIP for CORDStrom™

TD SYNNEX Reports Record Fiscal 2026 Second Quarter Results

Montauk Brewing Kicks Off Summer with 14th Anniversary Celebration, Limited Brew Barn Release and Beach Cleanup

Autolus Therapeutics to Participate in Upcoming Investor Conference

Constellation Announces Extension of Expiration for Exchange Offers

Seres Therapeutics to Host Webcast on July 8, 2026, to Discuss Results of Investigator-Sponsored Trial of Seres’ SER-155 in Immune Checkpoint Inhibitor-Related Enterocolitis

Darden Restaurants Reports Fiscal 2026 Fourth Quarter and Full Year Results; Increases Quarterly Dividend; Authorizes New $1.5 Billion Share Repurchase Program; and Provides Fiscal 2027 Outlook

Z Squared, Inc. to Acquire Majority Interest in Paradox Data and Its Union County Campus, a Next-Generation Data Center Development Targeting Up to 150 MW of Firm Power

Atea Pharmaceuticals Completes Patient Enrollment in Phase 3 C-FORWARD Trial Evaluating Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus